0001179110-18-008527.txt : 20180614
0001179110-18-008527.hdr.sgml : 20180614
20180614164749
ACCESSION NUMBER: 0001179110-18-008527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180612
FILED AS OF DATE: 20180614
DATE AS OF CHANGE: 20180614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOVEN ANDREW I
CENTRAL INDEX KEY: 0001258673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 18899726
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE, SUITE 1710
STREET 2: C/O ARALEZ PHARMACEUTICALS INC.
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
edgar.xml
FORM 4 -
X0306
4
2018-06-12
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001258673
KOVEN ANDREW I
C/O KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201
WALTHAM
MA
02453
1
0
0
0
Stock Option (right to buy)
13.73
2018-06-12
4
A
0
12960
0
A
2028-06-11
Common Stock
12960
12960
D
This option was granted on June 12, 2018 and vests in equal monthly installments until the one-year anniversary of the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
/s/ Mary Reumuth, Attorney-in-Fact
2018-06-14